CClinicalTrials.gg
CompletedNCT04805073Updated May 4, 2025Results posted

Treatment of Pruritus With Intramuscular Promethazine

A Phase 4 interventional study of Promethazine and Placebo in Pruritus and Pregnancy Related, sponsored by University of Florida. Completed at 1 site in United States. Open to female participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-04.

Sponsored by University of Florida · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
Female
01

Study summary

Neuraxial narcotics are commonly used in obstetric patients for cesarean delivery to help with pain control over the first 24 hours after the surgery. The aim is to evaluate effectiveness of promethazine (IMP) treatment of intrathecal morphine induced pruritus (ITIMIP). A treatment for ITMIP, other than naloxone, will allow for increased use of intrathecal narcotics and decrease the use of systemic opioids in the initial post-operative period.

02

Conditions studied

  • Pruritus
  • Pregnancy Related

Browse trials for

Keywords

  • cesarean section
03

In context

Pruritus

354 studies on the registry are indexed under Pruritus; 74 are open to participants now.

This study's enrollment of 72 is above the median of 60 across 294 interventional studies indexed under Pruritus.

Browse Pruritus studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pregnant adult female patients of at least 18 years of age consenting to a cesarean birth
  • Willing to consent to study.

Exclusion criteria

Exclusion Criteria:

  • Male patients
  • Incarceration
  • Inability to communicate with the investigators
  • Allergies to any medications used in the study
  • Possessing any contraindication to spinal anesthesia (lack of consent, elevated intracranial pressure, preexisting neurological disease, thrombocytopenia/coagulopathy, hypovolemia, infection at the site of the procedure)
  • Patients with an already prolonged QTc (>500 ms)
  • Any reason an investigator believes study participation would not be in the best interest of the potential subject.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Promethazine

    The treatment will consist of a blinded syringe of 1cc clear liquid 25mg/ml Promethazine

    Drug: Promethazine

  • Placebo comparator
    Placebo

    The treatment will consist of a blinded syringe of 1cc 0.9% Sodium Chloride

    Drug: Placebo

Interventions

  • DrugPromethazine

    1cc 25mg/ml Promethazine (study medication)

    Also known as: Phenergan

  • DrugPlacebo

    1cc 0.9% Sodium Chloride (placebo)

    Also known as: salt water

06

What researchers measure

Primary outcomes

  1. Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?

    Pruritus (itching) will be quantified by the ItchyQuant Scale. The ItchyQuant scale is a 0 -10 scale with 0 denoting no itch and 10, the worst itch possible. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their itching. In the results here we reported any itching (a score greater than zero on the ItchyQuant scale) at 24 hours after surgery in each group.

    Time frame: Within first 24 hours after cesarean section

Secondary outcomes

  1. Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?

    Level of consciousness will be quantified by the RASS Scale. The RASS scale is scored with +4 to -5 scale with +4=combative, 0=alert and calm and -5=unrousable. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their level of consciousness. In the results here we reported any score not noted to be 0 (alert and calm) at 24 hours after surgery in each group.

    Time frame: Within first 24 hours post cesarean section

  2. Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?

    We asked patients to rate their sensation of nausea and/or vomiting as none, mild, moderate or severe at 4 time points after cesarean (1 hour, 4 hours and 24 hours after cesarean). Here, we rate any report of nausea and/or vomiting as opposed to no nausea and/or vomiting at 24 hours after cesarean among the patients who had Promethazine and normal saline.

    Time frame: Within first 24 hours post cesarean section

07

Results

Posted May 4, 2025
Limitations and caveats
We failed to enroll the planned number of patients due to a variety of factors, including challenges in availability of the study drug coupled with slow enrollment. Over two-thirds of the patients who were screened and were able to be contacted prior to surgery declined to participate. This did not support continuing enrollment.

Participant flow

Participant flow — Overall Study
MilestonePromethazinePlacebo
Started3636
Completed3433
Not completed23
Withdrew: Study personnel not available20
Withdrew: Spinal anesthesia failure01
Withdrew: Lost to follow-up02

Outcome measures

PrimaryDoes the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?

Pruritus (itching) will be quantified by the ItchyQuant Scale. The ItchyQuant scale is a 0 -10 scale with 0 denoting no itch and 10, the worst itch possible. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their itching. In the results here we reported any itching (a score greater than zero on the ItchyQuant scale) at 24 hours after surgery in each group.

Time frame:
Within first 24 hours after cesarean section
Reported as:
Count of participants · Participants
Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?
ParticipantsPromethazinePlacebo
No Itching at 24 hour2217
Itching at 24 hour1015
SecondaryDoes Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?

Level of consciousness will be quantified by the RASS Scale. The RASS scale is scored with +4 to -5 scale with +4=combative, 0=alert and calm and -5=unrousable. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their level of consciousness. In the results here we reported any score not noted to be 0 (alert and calm) at 24 hours after surgery in each group.

Time frame:
Within first 24 hours post cesarean section
Reported as:
Count of participants · Participants
Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?
ParticipantsPromethazinePlacebo
Alert and Calm at 24 hour3231
Not Alert and Calm at 24 hour01
SecondaryDoes Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?

We asked patients to rate their sensation of nausea and/or vomiting as none, mild, moderate or severe at 4 time points after cesarean (1 hour, 4 hours and 24 hours after cesarean). Here, we rate any report of nausea and/or vomiting as opposed to no nausea and/or vomiting at 24 hours after cesarean among the patients who had Promethazine and normal saline.

Time frame:
Within first 24 hours post cesarean section
Reported as:
Count of participants · Participants
Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?
ParticipantsPromethazinePlacebo
No nausea or vomiting at 24 hours3132
Nausea and/or vomiting at 24 hours10

Adverse events

Collected over 24 hours after study drug administration. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Promethazine0/34 (0%)0/34 (0%)0/34 (0%)
Placebo0/33 (0%)0/33 (0%)0/33 (0%)

Baseline characteristics

Not recorded

Age, Categorical
Age, Categorical(Participants)PromethazinePlaceboTotal
<=18 years000
Between 18 and 65 years363672
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)PromethazinePlaceboTotal
Female363672
Male000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)PromethazinePlaceboTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)PromethazinePlaceboTotal
United States363672
08

Study locations

1 site
  • UF Health at the University of Florida
    Gainesville, Florida 32610, United States
09

References and documents

Publications

  • Morgan PJ, Mehta S, Kapala DM. Nalbuphine pretreatment in cesarean section patients receiving epidural morphine. Reg Anesth. 1991 Mar-Apr;16(2):84-8. PubMed 2043531 ↗
  • Cohen SE, Ratner EF, Kreitzman TR, Archer JH, Mignano LR. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg. 1992 Nov;75(5):747-52. PubMed 1416128 ↗
  • Vice-O'Con K, Austin PN, Pugh MA. Pharmacologic Methods for Preventing Pruritus in Patients Receiving Intrathecal Opioids for Cesarean Delivery. AANA J. 2018 Feb;86(1):59-66. PubMed 31573495 ↗
  • Penning JP, Samson B, Baxter AD. Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can J Anaesth. 1988 Nov;35(6):599-604. doi: 10.1007/BF03020347. PubMed 3144443 ↗
  • Alhashemi JA, Crosby ET, Grodecki W, Duffy PJ, Hull KA, Gallant C. Treatment of intrathecal morphine-induced pruritus following caesarean section. Can J Anaesth. 1997 Oct;44(10):1060-5. doi: 10.1007/BF03019227. PubMed 9350364 ↗
  • Ituk U, Habib AS. Enhanced recovery after cesarean delivery. F1000Res. 2018 Apr 27;7:F1000 Faculty Rev-513. doi: 10.12688/f1000research.13895.1. eCollection 2018. PubMed 29770203 ↗
  • Singh PM, Sultan P, O'Carroll J, Blake L, Carvalho B, Singh NP, Monks DT. Pharmacological agents for prevention of pruritus in women undergoing Caesarean delivery with neuraxial morphine: a systematic review and Bayesian network meta-analysis. Br J Anaesth. 2023 Sep;131(3):556-571. doi: 10.1016/j.bja.2023.05.028. Epub 2023 Jul 14. PubMed 37455197 ↗
  • Moustafa AA, Baaror AS, Abdelazim IA. Comparative study between nalbuphine and ondansetron in prevention of intrathecal morphine-induced pruritus in women undergoing cesarean section. Anesth Essays Res. 2016 May-Aug;10(2):238-44. doi: 10.4103/0259-1162.167839. PubMed 27212754 ↗
  • Charuluxananan S, Somboonviboon W, Kyokong O, Nimcharoendee K. Ondansetron for treatment of intrathecal morphine-induced pruritus after cesarean delivery. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):535-9. doi: 10.1053/rapm.2000.7809. PubMed 11009242 ↗
  • Sultan P, Halpern SH, Pushpanathan E, Patel S, Carvalho B. The Effect of Intrathecal Morphine Dose on Outcomes After Elective Cesarean Delivery: A Meta-Analysis. Anesth Analg. 2016 Jul;123(1):154-64. doi: 10.1213/ANE.0000000000001255. PubMed 27089000 ↗
  • Kumar K, Singh SI. Neuraxial opioid-induced pruritus: An update. J Anaesthesiol Clin Pharmacol. 2013 Jul;29(3):303-7. doi: 10.4103/0970-9185.117045. PubMed 24106351 ↗
  • Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993 May;168(5):1393-9. doi: 10.1016/s0002-9378(11)90771-6. PubMed 8498418 ↗
  • Anwari JS, Iqbal S. Antihistamines and potentiation of opioid induced sedation and respiratory depression. Anaesthesia. 2003 May;58(5):494-5. doi: 10.1046/j.1365-2044.2003.03154_18.x. No abstract available. PubMed 12694022 ↗
  • Eldor J, Fishelev V, Levine S, Guedj P, Dudakova I. Prevention of epidural morphine pruritus by intramuscular promethazine in parturients. Reg Anesth. 1994 Nov-Dec;19(6):433-4. No abstract available. PubMed 7848959 ↗
  • Slappendel R, Weber EW, Benraad B, van Limbeek J, Dirksen R. Itching after intrathecal morphine. Incidence and treatment. Eur J Anaesthesiol. 2000 Oct;17(10):616-21. doi: 10.1046/j.1365-2346.2000.00727.x. PubMed 11050519 ↗
  • Horta ML, Morejon LC, da Cruz AW, Dos Santos GR, Welling LC, Terhorst L, Costa RC, Alam RU. Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. Br J Anaesth. 2006 Jun;96(6):796-800. doi: 10.1093/bja/ael072. Epub 2006 Apr 5. PubMed 16597655 ↗
  • Haydek CG, Love E, Mollanazar NK, Valdes Rodriguez R, Lee H, Yosipovitch G, Tharp MD, Hanifin JM, Chen KH, Chen SC. Validation and Banding of the ItchyQuant: A Self-Report Itch Severity Scale. J Invest Dermatol. 2017 Jan;137(1):57-61. doi: 10.1016/j.jid.2016.06.633. Epub 2016 Aug 10. PubMed 27521593 ↗
  • Koju RB, Gurung BS, Dongol Y. Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritus and post-operative nausea and vomiting in patients undergoing caesarean section. BMC Anesthesiol. 2015 Feb 17;15:18. doi: 10.1186/1471-2253-15-18. PubMed 25971957 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 22, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04805073
Lead sponsor
University of Florida
Responsible party
Sponsor
First posted
Mar 18, 2021
Start date
Aug 9, 2021
Primary completion
May 30, 2024
Completion
May 30, 2024
Results posted
May 4, 2025
Last update
May 4, 2025

Study contacts

Adam Wendling, MD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion